Viewing Study NCT06984159

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:49 PM

Ignite Modification Date: 2026-01-07 @ 8:02 AM

Study NCT ID: NCT06984159

Status: COMPLETED

Last Update Posted: 2025-05-22

First Post: 2025-05-11

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module